Table 3 Comparison of AK patient outcomes with respect to Acanthamoeba with and without endosymbionts
S. No. | Clinical features | Acanthamoeba with endosymbionts (n = 9) | Acanthamoeba without endosymbionts (n = 4) |
|---|---|---|---|
1 | Symptom duration at presentation, days (mean ± SD) | 43.0 ± 44.3 | 16.5 ± 5.1 |
2 | Reported risk factor (trauma and/or contact lens wear) | 55% (5/9) | 25% (1/4) |
3 | Observation of stromal infiltrate | 88.9% (8/9) | 50% (2/4) |
4 | Presence of hypopyon | 55.6% (5/9) | 25% (1/4) |
5 | Medical treatment duration, days (median, IQR) | 30.0 (17.0–91.8)§ | 75.0 (43.5–202.5) |
6 | Healing of ulcer | 66.6% (6/9) | 75% (3/4) |
7 | Improved final VA by ≥ 2 lines | 44.4% (4/9) | 50% (2/4) |